Kelun Biotech presents oncology study data at ESMO Congress
Biopharmaceutical firm Sichuan Kelun Biotech scheduled multiple research presentations detailing its oncology drug development pipeline at the European Society for Medical Oncology Congress in Madrid
We haven't written up this one. Vietnam Investment Review has the full story — the link below goes straight to it.